To further confirm the adverse prognostic roles of DYRK1A and NFATC1 transcriptional expression in patients with GBM, we downloaded and analyzed DYRK1A or NFATC1 transcription data from TCGA and KM Plotter datasets. Here, DYRK1A is linked to glioblastoma.